The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pirfenidone Market Research Report 2025
Synopsis
The global Pirfenidone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Pirfenidone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pirfenidone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pirfenidone include Genentech (Roche), Shionogi, GNI Group, Beijing Continent, Cipla, Lupin Ltd, Zydus Cadila, Glenmark Pharmaceuticals and Koye Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pirfenidone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pirfenidone.
Report Scope
The Pirfenidone market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pirfenidone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pirfenidone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Genentech (Roche)
Shionogi
GNI Group
Beijing Continent
Cipla
Lupin Ltd
Zydus Cadila
Glenmark Pharmaceuticals
Koye Pharmaceuticals
MSN Laboratories
Wockhardt
Incepta Pharmaceuticals
Unimed Unihealth
Segment by Type
Tablet
Capsule
Others
Segment by Application
Mild Idiopathic Pulmonary Fibrosis
Moderate Idiopathic Pulmonary Fibrosis
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pirfenidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pirfenidone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Pirfenidone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Pirfenidone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pirfenidone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pirfenidone include Genentech (Roche), Shionogi, GNI Group, Beijing Continent, Cipla, Lupin Ltd, Zydus Cadila, Glenmark Pharmaceuticals and Koye Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pirfenidone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pirfenidone.
Report Scope
The Pirfenidone market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pirfenidone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pirfenidone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Genentech (Roche)
Shionogi
GNI Group
Beijing Continent
Cipla
Lupin Ltd
Zydus Cadila
Glenmark Pharmaceuticals
Koye Pharmaceuticals
MSN Laboratories
Wockhardt
Incepta Pharmaceuticals
Unimed Unihealth
Segment by Type
Tablet
Capsule
Others
Segment by Application
Mild Idiopathic Pulmonary Fibrosis
Moderate Idiopathic Pulmonary Fibrosis
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pirfenidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pirfenidone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pirfenidone Market Overview
1.1 Product Overview and Scope of Pirfenidone
1.2 Pirfenidone Segment by Type
1.2.1 Global Pirfenidone Market Value Comparison by Type (2024-2030)
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Others
1.3 Pirfenidone Segment by Application
1.3.1 Global Pirfenidone Market Value by Application: (2024-2030)
1.3.2 Mild Idiopathic Pulmonary Fibrosis
1.3.3 Moderate Idiopathic Pulmonary Fibrosis
1.3.4 Others
1.4 Global Pirfenidone Market Size Estimates and Forecasts
1.4.1 Global Pirfenidone Revenue 2019-2030
1.4.2 Global Pirfenidone Sales 2019-2030
1.4.3 Global Pirfenidone Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pirfenidone Market Competition by Manufacturers
2.1 Global Pirfenidone Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pirfenidone Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pirfenidone Average Price by Manufacturers (2019-2024)
2.4 Global Pirfenidone Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pirfenidone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pirfenidone, Product Type & Application
2.7 Pirfenidone Market Competitive Situation and Trends
2.7.1 Pirfenidone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pirfenidone Players Market Share by Revenue
2.7.3 Global Pirfenidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pirfenidone Retrospective Market Scenario by Region
3.1 Global Pirfenidone Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pirfenidone Global Pirfenidone Sales by Region: 2019-2030
3.2.1 Global Pirfenidone Sales by Region: 2019-2024
3.2.2 Global Pirfenidone Sales by Region: 2025-2030
3.3 Global Pirfenidone Global Pirfenidone Revenue by Region: 2019-2030
3.3.1 Global Pirfenidone Revenue by Region: 2019-2024
3.3.2 Global Pirfenidone Revenue by Region: 2025-2030
3.4 North America Pirfenidone Market Facts & Figures by Country
3.4.1 North America Pirfenidone Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pirfenidone Sales by Country (2019-2030)
3.4.3 North America Pirfenidone Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pirfenidone Market Facts & Figures by Country
3.5.1 Europe Pirfenidone Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pirfenidone Sales by Country (2019-2030)
3.5.3 Europe Pirfenidone Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pirfenidone Market Facts & Figures by Country
3.6.1 Asia Pacific Pirfenidone Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pirfenidone Sales by Country (2019-2030)
3.6.3 Asia Pacific Pirfenidone Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pirfenidone Market Facts & Figures by Country
3.7.1 Latin America Pirfenidone Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pirfenidone Sales by Country (2019-2030)
3.7.3 Latin America Pirfenidone Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pirfenidone Market Facts & Figures by Country
3.8.1 Middle East and Africa Pirfenidone Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pirfenidone Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pirfenidone Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pirfenidone Sales by Type (2019-2030)
4.1.1 Global Pirfenidone Sales by Type (2019-2024)
4.1.2 Global Pirfenidone Sales by Type (2025-2030)
4.1.3 Global Pirfenidone Sales Market Share by Type (2019-2030)
4.2 Global Pirfenidone Revenue by Type (2019-2030)
4.2.1 Global Pirfenidone Revenue by Type (2019-2024)
4.2.2 Global Pirfenidone Revenue by Type (2025-2030)
4.2.3 Global Pirfenidone Revenue Market Share by Type (2019-2030)
4.3 Global Pirfenidone Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pirfenidone Sales by Application (2019-2030)
5.1.1 Global Pirfenidone Sales by Application (2019-2024)
5.1.2 Global Pirfenidone Sales by Application (2025-2030)
5.1.3 Global Pirfenidone Sales Market Share by Application (2019-2030)
5.2 Global Pirfenidone Revenue by Application (2019-2030)
5.2.1 Global Pirfenidone Revenue by Application (2019-2024)
5.2.2 Global Pirfenidone Revenue by Application (2025-2030)
5.2.3 Global Pirfenidone Revenue Market Share by Application (2019-2030)
5.3 Global Pirfenidone Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Genentech (Roche)
6.1.1 Genentech (Roche) Corporation Information
6.1.2 Genentech (Roche) Description and Business Overview
6.1.3 Genentech (Roche) Pirfenidone Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Genentech (Roche) Pirfenidone Product Portfolio
6.1.5 Genentech (Roche) Recent Developments/Updates
6.2 Shionogi
6.2.1 Shionogi Corporation Information
6.2.2 Shionogi Description and Business Overview
6.2.3 Shionogi Pirfenidone Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Shionogi Pirfenidone Product Portfolio
6.2.5 Shionogi Recent Developments/Updates
6.3 GNI Group
6.3.1 GNI Group Corporation Information
6.3.2 GNI Group Description and Business Overview
6.3.3 GNI Group Pirfenidone Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GNI Group Pirfenidone Product Portfolio
6.3.5 GNI Group Recent Developments/Updates
6.4 Beijing Continent
6.4.1 Beijing Continent Corporation Information
6.4.2 Beijing Continent Description and Business Overview
6.4.3 Beijing Continent Pirfenidone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Beijing Continent Pirfenidone Product Portfolio
6.4.5 Beijing Continent Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Corporation Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Pirfenidone Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cipla Pirfenidone Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 Lupin Ltd
6.6.1 Lupin Ltd Corporation Information
6.6.2 Lupin Ltd Description and Business Overview
6.6.3 Lupin Ltd Pirfenidone Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lupin Ltd Pirfenidone Product Portfolio
6.6.5 Lupin Ltd Recent Developments/Updates
6.7 Zydus Cadila
6.6.1 Zydus Cadila Corporation Information
6.6.2 Zydus Cadila Description and Business Overview
6.6.3 Zydus Cadila Pirfenidone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zydus Cadila Pirfenidone Product Portfolio
6.7.5 Zydus Cadila Recent Developments/Updates
6.8 Glenmark Pharmaceuticals
6.8.1 Glenmark Pharmaceuticals Corporation Information
6.8.2 Glenmark Pharmaceuticals Description and Business Overview
6.8.3 Glenmark Pharmaceuticals Pirfenidone Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Glenmark Pharmaceuticals Pirfenidone Product Portfolio
6.8.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.9 Koye Pharmaceuticals
6.9.1 Koye Pharmaceuticals Corporation Information
6.9.2 Koye Pharmaceuticals Description and Business Overview
6.9.3 Koye Pharmaceuticals Pirfenidone Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Koye Pharmaceuticals Pirfenidone Product Portfolio
6.9.5 Koye Pharmaceuticals Recent Developments/Updates
6.10 MSN Laboratories
6.10.1 MSN Laboratories Corporation Information
6.10.2 MSN Laboratories Description and Business Overview
6.10.3 MSN Laboratories Pirfenidone Sales, Revenue and Gross Margin (2019-2024)
6.10.4 MSN Laboratories Pirfenidone Product Portfolio
6.10.5 MSN Laboratories Recent Developments/Updates
6.11 Wockhardt
6.11.1 Wockhardt Corporation Information
6.11.2 Wockhardt Pirfenidone Description and Business Overview
6.11.3 Wockhardt Pirfenidone Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Wockhardt Pirfenidone Product Portfolio
6.11.5 Wockhardt Recent Developments/Updates
6.12 Incepta Pharmaceuticals
6.12.1 Incepta Pharmaceuticals Corporation Information
6.12.2 Incepta Pharmaceuticals Pirfenidone Description and Business Overview
6.12.3 Incepta Pharmaceuticals Pirfenidone Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Incepta Pharmaceuticals Pirfenidone Product Portfolio
6.12.5 Incepta Pharmaceuticals Recent Developments/Updates
6.13 Unimed Unihealth
6.13.1 Unimed Unihealth Corporation Information
6.13.2 Unimed Unihealth Pirfenidone Description and Business Overview
6.13.3 Unimed Unihealth Pirfenidone Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Unimed Unihealth Pirfenidone Product Portfolio
6.13.5 Unimed Unihealth Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pirfenidone Industry Chain Analysis
7.2 Pirfenidone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pirfenidone Production Mode & Process
7.4 Pirfenidone Sales and Marketing
7.4.1 Pirfenidone Sales Channels
7.4.2 Pirfenidone Distributors
7.5 Pirfenidone Customers
8 Pirfenidone Market Dynamics
8.1 Pirfenidone Industry Trends
8.2 Pirfenidone Market Drivers
8.3 Pirfenidone Market Challenges
8.4 Pirfenidone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pirfenidone Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pirfenidone Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Pirfenidone Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pirfenidone Sales (K Pcs) of Key Manufacturers (2019-2024)
Table 5. Global Pirfenidone Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pirfenidone Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pirfenidone Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pirfenidone Average Price (USD/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pirfenidone, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pirfenidone, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pirfenidone, Product Type & Application
Table 12. Global Key Manufacturers of Pirfenidone, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pirfenidone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pirfenidone as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pirfenidone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pirfenidone Sales by Region (2019-2024) & (K Pcs)
Table 18. Global Pirfenidone Sales Market Share by Region (2019-2024)
Table 19. Global Pirfenidone Sales by Region (2025-2030) & (K Pcs)
Table 20. Global Pirfenidone Sales Market Share by Region (2025-2030)
Table 21. Global Pirfenidone Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pirfenidone Revenue Market Share by Region (2019-2024)
Table 23. Global Pirfenidone Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pirfenidone Revenue Market Share by Region (2025-2030)
Table 25. North America Pirfenidone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pirfenidone Sales by Country (2019-2024) & (K Pcs)
Table 27. North America Pirfenidone Sales by Country (2025-2030) & (K Pcs)
Table 28. North America Pirfenidone Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pirfenidone Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pirfenidone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pirfenidone Sales by Country (2019-2024) & (K Pcs)
Table 32. Europe Pirfenidone Sales by Country (2025-2030) & (K Pcs)
Table 33. Europe Pirfenidone Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pirfenidone Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pirfenidone Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pirfenidone Sales by Region (2019-2024) & (K Pcs)
Table 37. Asia Pacific Pirfenidone Sales by Region (2025-2030) & (K Pcs)
Table 38. Asia Pacific Pirfenidone Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pirfenidone Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pirfenidone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pirfenidone Sales by Country (2019-2024) & (K Pcs)
Table 42. Latin America Pirfenidone Sales by Country (2025-2030) & (K Pcs)
Table 43. Latin America Pirfenidone Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pirfenidone Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pirfenidone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Pirfenidone Sales by Country (2019-2024) & (K Pcs)
Table 47. Middle East & Africa Pirfenidone Sales by Country (2025-2030) & (K Pcs)
Table 48. Middle East & Africa Pirfenidone Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pirfenidone Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pirfenidone Sales (K Pcs) by Type (2019-2024)
Table 51. Global Pirfenidone Sales (K Pcs) by Type (2025-2030)
Table 52. Global Pirfenidone Sales Market Share by Type (2019-2024)
Table 53. Global Pirfenidone Sales Market Share by Type (2025-2030)
Table 54. Global Pirfenidone Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pirfenidone Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pirfenidone Revenue Market Share by Type (2019-2024)
Table 57. Global Pirfenidone Revenue Market Share by Type (2025-2030)
Table 58. Global Pirfenidone Price (USD/Pcs) by Type (2019-2024)
Table 59. Global Pirfenidone Price (USD/Pcs) by Type (2025-2030)
Table 60. Global Pirfenidone Sales (K Pcs) by Application (2019-2024)
Table 61. Global Pirfenidone Sales (K Pcs) by Application (2025-2030)
Table 62. Global Pirfenidone Sales Market Share by Application (2019-2024)
Table 63. Global Pirfenidone Sales Market Share by Application (2025-2030)
Table 64. Global Pirfenidone Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pirfenidone Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pirfenidone Revenue Market Share by Application (2019-2024)
Table 67. Global Pirfenidone Revenue Market Share by Application (2025-2030)
Table 68. Global Pirfenidone Price (USD/Pcs) by Application (2019-2024)
Table 69. Global Pirfenidone Price (USD/Pcs) by Application (2025-2030)
Table 70. Genentech (Roche) Corporation Information
Table 71. Genentech (Roche) Description and Business Overview
Table 72. Genentech (Roche) Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 73. Genentech (Roche) Pirfenidone Product
Table 74. Genentech (Roche) Recent Developments/Updates
Table 75. Shionogi Corporation Information
Table 76. Shionogi Description and Business Overview
Table 77. Shionogi Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 78. Shionogi Pirfenidone Product
Table 79. Shionogi Recent Developments/Updates
Table 80. GNI Group Corporation Information
Table 81. GNI Group Description and Business Overview
Table 82. GNI Group Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 83. GNI Group Pirfenidone Product
Table 84. GNI Group Recent Developments/Updates
Table 85. Beijing Continent Corporation Information
Table 86. Beijing Continent Description and Business Overview
Table 87. Beijing Continent Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 88. Beijing Continent Pirfenidone Product
Table 89. Beijing Continent Recent Developments/Updates
Table 90. Cipla Corporation Information
Table 91. Cipla Description and Business Overview
Table 92. Cipla Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 93. Cipla Pirfenidone Product
Table 94. Cipla Recent Developments/Updates
Table 95. Lupin Ltd Corporation Information
Table 96. Lupin Ltd Description and Business Overview
Table 97. Lupin Ltd Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 98. Lupin Ltd Pirfenidone Product
Table 99. Lupin Ltd Recent Developments/Updates
Table 100. Zydus Cadila Corporation Information
Table 101. Zydus Cadila Description and Business Overview
Table 102. Zydus Cadila Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 103. Zydus Cadila Pirfenidone Product
Table 104. Zydus Cadila Recent Developments/Updates
Table 105. Glenmark Pharmaceuticals Corporation Information
Table 106. Glenmark Pharmaceuticals Description and Business Overview
Table 107. Glenmark Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 108. Glenmark Pharmaceuticals Pirfenidone Product
Table 109. Glenmark Pharmaceuticals Recent Developments/Updates
Table 110. Koye Pharmaceuticals Corporation Information
Table 111. Koye Pharmaceuticals Description and Business Overview
Table 112. Koye Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 113. Koye Pharmaceuticals Pirfenidone Product
Table 114. Koye Pharmaceuticals Recent Developments/Updates
Table 115. MSN Laboratories Corporation Information
Table 116. MSN Laboratories Description and Business Overview
Table 117. MSN Laboratories Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 118. MSN Laboratories Pirfenidone Product
Table 119. MSN Laboratories Recent Developments/Updates
Table 120. Wockhardt Corporation Information
Table 121. Wockhardt Description and Business Overview
Table 122. Wockhardt Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 123. Wockhardt Pirfenidone Product
Table 124. Wockhardt Recent Developments/Updates
Table 125. Incepta Pharmaceuticals Corporation Information
Table 126. Incepta Pharmaceuticals Description and Business Overview
Table 127. Incepta Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 128. Incepta Pharmaceuticals Pirfenidone Product
Table 129. Incepta Pharmaceuticals Recent Developments/Updates
Table 130. Unimed Unihealth Corporation Information
Table 131. Unimed Unihealth Description and Business Overview
Table 132. Unimed Unihealth Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 133. Unimed Unihealth Pirfenidone Product
Table 134. Unimed Unihealth Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Pirfenidone Distributors List
Table 138. Pirfenidone Customers List
Table 139. Pirfenidone Market Trends
Table 140. Pirfenidone Market Drivers
Table 141. Pirfenidone Market Challenges
Table 142. Pirfenidone Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pirfenidone
Figure 2. Global Pirfenidone Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pirfenidone Market Share by Type in 2023 & 2030
Figure 4. Tablet Product Picture
Figure 5. Capsule Product Picture
Figure 6. Others Product Picture
Figure 7. Global Pirfenidone Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Pirfenidone Market Share by Application in 2023 & 2030
Figure 9. Mild Idiopathic Pulmonary Fibrosis
Figure 10. Moderate Idiopathic Pulmonary Fibrosis
Figure 11. Others
Figure 12. Global Pirfenidone Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Pirfenidone Market Size (2019-2030) & (US$ Million)
Figure 14. Global Pirfenidone Sales (2019-2030) & (K Pcs)
Figure 15. Global Pirfenidone Average Price (USD/Pcs) & (2019-2030)
Figure 16. Pirfenidone Report Years Considered
Figure 17. Pirfenidone Sales Share by Manufacturers in 2023
Figure 18. Global Pirfenidone Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Pirfenidone Players: Market Share by Revenue in 2023
Figure 20. Pirfenidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Pirfenidone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Pirfenidone Sales Market Share by Country (2019-2030)
Figure 23. North America Pirfenidone Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Pirfenidone Sales Market Share by Country (2019-2030)
Figure 27. Europe Pirfenidone Revenue Market Share by Country (2019-2030)
Figure 28. Germany Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Pirfenidone Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Pirfenidone Revenue Market Share by Region (2019-2030)
Figure 35. China Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Pirfenidone Sales Market Share by Country (2019-2030)
Figure 46. Latin America Pirfenidone Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Pirfenidone Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Pirfenidone Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Pirfenidone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Pirfenidone by Type (2019-2030)
Figure 56. Global Revenue Market Share of Pirfenidone by Type (2019-2030)
Figure 57. Global Pirfenidone Price (USD/Pcs) by Type (2019-2030)
Figure 58. Global Sales Market Share of Pirfenidone by Application (2019-2030)
Figure 59. Global Revenue Market Share of Pirfenidone by Application (2019-2030)
Figure 60. Global Pirfenidone Price (USD/Pcs) by Application (2019-2030)
Figure 61. Pirfenidone Value Chain
Figure 62. Pirfenidone Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
